article · Health Science Reports
The findings indicate that while single-substance use of alcohol or cannabis had limited impact on hemoglobin and lipid profiles, dual use was associated with elevated hemoglobin and marked liver enzyme abnormalities. Elevated AST, GGT, and bilirubin in substance users, particularly dual users, suggest potential hepatic stress, warranting targeted public health interventions and monitoring. It is recommended that routine liver function screening be incorporated into healthcare services for individuals with a history of alcohol and cannabis use to enable early detection and management of hepatic impairment.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1002/hsr2.71908
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.